Wealth Enhancement Advisory Services
VYGR icon

Wealth Enhancement Advisory Services’s Voyager Therapeutics VYGR Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$55.2K Buy
16,052
+5,556
+53% +$21.1K ﹤0.01% 3905
2026
Q1 		$41.6K Buy
+10,496
New +$41.3K ﹤0.01% 3447

Other funds holding VYGR

PFGIA
Patriot Financial Group Insurance Agency Westborough, Massachusetts $974M AUM 29.77% 1-Year Est. Return
HPCM
Hunter Perkins Capital Management Lombard, Illinois $446M AUM 25.88% 1-Year Est. Return
DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Wealth Enhancement Advisory Services's VYGR Position: Q2 2026 in Review

Wealth Enhancement Advisory Services increased its Voyager Therapeutics (VYGR) stake by 53% in Q2 2026, buying an estimated $21.1K and bringing the position to 16,052 shares worth $55.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3905.

Wealth Enhancement Advisory Services first reported a position in VYGR in Q1 2026 and has held it in 2 quarters since. 15 funds tracked by Wall St. Rank hold VYGR as of Q2 2026.

  • Wealth Enhancement Advisory Services held 16,052 shares of Voyager Therapeutics worth $55.2K as of Q2 2026.
  • Wealth Enhancement Advisory Services bought 5,556 Voyager Therapeutics shares in Q2 2026, an estimated $21.1K.
  • Voyager Therapeutics made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #3905 holding.
  • Wealth Enhancement Advisory Services first reported a position in Voyager Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 15 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.